FDA Approves First New Weight-Loss Pill In Decade
WASHINGTON — The Food and Drug Administration has approved Arena Pharmaceutical’s anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade.
Read MoreA Supreme Court split decision will cause health confusion
Utter confusion could result if the Supreme Court invalidates the Affordable Care Act’s (ACA) individual mandate while upholding other parts of the law, a physician expert predicted ahead of Thursday’s expected decision.
Read MoreNews
Heartburn pills taken by millions ‘can increase risk of cancer and heart disease
Heartburn can make your life a misery. Meals become times of dread as you wait for the sharp, insistent pain that follows when acid seeps from the valve at the top of your stomach.
News
Novartis Wins U.S. Approval for Afinitor in Breast Cancer
Novartis AG (NOVN) won U.S. approval to market its cancer drug Afinitor for breast tumors, an achievement that may add more than $1 billion in annual sales.
News
Diabetes drug costing just 2p could beat prostate cancer by shrinking tumours
A diabetes drug costing as little as 2p a tablet could offer a major breakthrough in the treatment of prostate cancer.